Danshensu, CAS [[76822-21-4]] Preis auf Anfrage

Artikelnummer: MCE-HY-N1913
Artikelname: Danshensu, CAS [[76822-21-4]] Preis auf Anfrage
Artikelnummer: MCE-HY-N1913
Hersteller Artikelnummer: HY-N1913
Alternativnummer: MCE-HY-N1913-100MG,MCE-HY-N1913-5MG,MCE-HY-N1913-10MMX1ML,MCE-HY-N1913-50MG,MCE-HY-N1913-10MG
Hersteller: MedchemExpress
Kategorie: Biochemikalien
Alternative Synonym: Dan shen suan A, Salvianic acid A
Danshensu (Dan shen suan A), an orally active phenolic compound, can induce Nrf2/HO-1 activation and inhibition of NF-kappaB pathway. Danshensu reduces reactive oxygen species (ROS) production, upregulates antioxidant defense mechanism and inhibits intrinsic apoptotic pathway. Danshensu displays a potent antiviral activity against SARS-CoV-2 with EC50 of 0.97 µM. Danshensu has anti-oxidation, anti-apoptosis, anti-lung inflammatory and has the potential for COVID-19, cardiovascular and cerebrovascular diseases research[1][2][3].
Molekulargewicht: 198.17
Reinheit: 98.59
CAS Nummer: [76822-21-4]
Formel: C9H10O5
Target-Kategorie: Apoptosis,Keap1-Nrf2,NF-kappaB,Reactive Oxygen Species (ROS),SARS-CoV
Anwendungsbeschreibung: MCE Product type: Natural Products